Eniluracil blocks AREG signalling‐induced pro‐inflammatory fibroblasts of melanoma in heart failure

Abstract Aims Heart failure (HF) is characterized by a heightened risk of melanoma, which often metastasizes to the heart. The overlap pathology between HF and melanoma includes chronic low‐grade inflammation and dysregulation of inflammatory cancer‐associated fibroblasts (iCAFs). The impact of HF o...

Full description

Saved in:
Bibliographic Details
Main Authors: Qin Ran, Long Chen
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.15110
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850152438704635904
author Qin Ran
Long Chen
author_facet Qin Ran
Long Chen
author_sort Qin Ran
collection DOAJ
description Abstract Aims Heart failure (HF) is characterized by a heightened risk of melanoma, which often metastasizes to the heart. The overlap pathology between HF and melanoma includes chronic low‐grade inflammation and dysregulation of inflammatory cancer‐associated fibroblasts (iCAFs). The impact of HF on iCAF‐driven tumour inflammation remains obscure. Methods and Results To identify critical genes for HF development, transcriptomic data (GSE57338) containing 313 clinical HF samples [136 healthy controls, 95 ischaemia (ISCH) and 82 dilated cardiomyopathy (DCM)] were analysed to screen differentially expressed genes (DEGs) and perform enrichment analysis. Fifty‐one DEGs in ISCH and 62 DEGs in DCM were identified with log2|fold change (FC)| ≥ 1 and P value ≤0.05. All these genes are involved in extracellular matrix organization, immune/inflammatory responses and Wnt signalling pathways. Then, the overall survival curves and prognostic models of DEGs in melanoma were evaluated. The correlation of gene expression with lymphocyte infiltration levels was assessed. Only aldehyde oxidase 1 (AOX1) and amphiregulin (AREG) maintained the same trend in melanoma as in HF, negatively affecting prognosis by regulating lymphocyte infiltration (log‐rank P value = 0.0017 and 0.0019). The potential drug molecules were screened, and the binding energies were calculated via molecular docking. Eniluracil, a known AOX1 targeting drug, was found to stably bind with AREG (hydrogen bond binding energies: −65.633, −63.592 and −62.813 kcal/mol). Conclusions The increased prevalence of melanoma in HF patients and its propensity for cardiac metastasis may be due to AREG‐mediated systemic low‐grade inflammation. Eniluracil holds promise as a therapeutic agent that may block AREG signalling, inhibiting the activation of iCAF mediated by regulatory T cell (Treg) and neutrophil.
format Article
id doaj-art-e247719ba39d4b9ba7f104610a05f72a
institution OA Journals
issn 2055-5822
language English
publishDate 2025-02-01
publisher Wiley
record_format Article
series ESC Heart Failure
spelling doaj-art-e247719ba39d4b9ba7f104610a05f72a2025-08-20T02:25:59ZengWileyESC Heart Failure2055-58222025-02-0112152554110.1002/ehf2.15110Eniluracil blocks AREG signalling‐induced pro‐inflammatory fibroblasts of melanoma in heart failureQin Ran0Long Chen1Chengdu Seventh People's Hospital Chengdu Sichuan ChinaDepartment of Immunology, School of Basic Medical Sciences Chengdu Medical College Chengdu Sichuan ChinaAbstract Aims Heart failure (HF) is characterized by a heightened risk of melanoma, which often metastasizes to the heart. The overlap pathology between HF and melanoma includes chronic low‐grade inflammation and dysregulation of inflammatory cancer‐associated fibroblasts (iCAFs). The impact of HF on iCAF‐driven tumour inflammation remains obscure. Methods and Results To identify critical genes for HF development, transcriptomic data (GSE57338) containing 313 clinical HF samples [136 healthy controls, 95 ischaemia (ISCH) and 82 dilated cardiomyopathy (DCM)] were analysed to screen differentially expressed genes (DEGs) and perform enrichment analysis. Fifty‐one DEGs in ISCH and 62 DEGs in DCM were identified with log2|fold change (FC)| ≥ 1 and P value ≤0.05. All these genes are involved in extracellular matrix organization, immune/inflammatory responses and Wnt signalling pathways. Then, the overall survival curves and prognostic models of DEGs in melanoma were evaluated. The correlation of gene expression with lymphocyte infiltration levels was assessed. Only aldehyde oxidase 1 (AOX1) and amphiregulin (AREG) maintained the same trend in melanoma as in HF, negatively affecting prognosis by regulating lymphocyte infiltration (log‐rank P value = 0.0017 and 0.0019). The potential drug molecules were screened, and the binding energies were calculated via molecular docking. Eniluracil, a known AOX1 targeting drug, was found to stably bind with AREG (hydrogen bond binding energies: −65.633, −63.592 and −62.813 kcal/mol). Conclusions The increased prevalence of melanoma in HF patients and its propensity for cardiac metastasis may be due to AREG‐mediated systemic low‐grade inflammation. Eniluracil holds promise as a therapeutic agent that may block AREG signalling, inhibiting the activation of iCAF mediated by regulatory T cell (Treg) and neutrophil.https://doi.org/10.1002/ehf2.15110AREGeniluracilheart failureiCAFmelanoma
spellingShingle Qin Ran
Long Chen
Eniluracil blocks AREG signalling‐induced pro‐inflammatory fibroblasts of melanoma in heart failure
ESC Heart Failure
AREG
eniluracil
heart failure
iCAF
melanoma
title Eniluracil blocks AREG signalling‐induced pro‐inflammatory fibroblasts of melanoma in heart failure
title_full Eniluracil blocks AREG signalling‐induced pro‐inflammatory fibroblasts of melanoma in heart failure
title_fullStr Eniluracil blocks AREG signalling‐induced pro‐inflammatory fibroblasts of melanoma in heart failure
title_full_unstemmed Eniluracil blocks AREG signalling‐induced pro‐inflammatory fibroblasts of melanoma in heart failure
title_short Eniluracil blocks AREG signalling‐induced pro‐inflammatory fibroblasts of melanoma in heart failure
title_sort eniluracil blocks areg signalling induced pro inflammatory fibroblasts of melanoma in heart failure
topic AREG
eniluracil
heart failure
iCAF
melanoma
url https://doi.org/10.1002/ehf2.15110
work_keys_str_mv AT qinran eniluracilblocksaregsignallinginducedproinflammatoryfibroblastsofmelanomainheartfailure
AT longchen eniluracilblocksaregsignallinginducedproinflammatoryfibroblastsofmelanomainheartfailure